AcelRx Pharmaceuticals

$1.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ACRX and other stocks, options, and ETFs commission-free!

About ACRX

AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. Its products include sufentanil, DZUVEO, DSUVIA ZALVISO US and ZALVISO EU. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA. The listed name for ACRX is AcelRx Pharmaceuticals, Inc. Common Stock.

CEO

Vincent J. Angotti

Employees

Headquarters

Redwood City, California

Founded

2005

Market Cap

192.68M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

14.27M

High Today

$1.92

Low Today

$1.81

Open Price

$1.89

Volume

6.37M

52 Week High

$2.94

52 Week Low

$0.7014

Collections

Technology

Health

North America

ACRX Earnings

-$0.22

-$0.15

-$0.07

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 15, After Hours